Diabetic Gastroparesis and its Emerging Therapeutic Options: A Narrative Review of the Literature
- PMID: 37814758
- PMCID: PMC10560130
- DOI: 10.7759/cureus.44870
Diabetic Gastroparesis and its Emerging Therapeutic Options: A Narrative Review of the Literature
Abstract
Diabetic gastroparesis (DG) is one of the many complications of diabetes mellitus (DM). Even though this condition surfaces years after uncontrolled disease, it affects the quality of life in several ways and causes significant morbidity. Common symptoms experienced by the patients include postprandial nausea, vomiting, abdominal fullness, and pain. Strict glycemic control is essential to evade the effects of DG. The purpose of this review article is to briefly study the pathophysiology, clinical features, diagnostic modalities, and the effects of DG on different aspects of life. Furthermore, it also focuses on the emerging treatment modalities for DG. Tradipitant and relamorelin are two such treatment options that are gaining noteworthy recognition and are discussed in detail in this review article. As observed through various clinical trials, these drugs help alleviate symptoms like nausea, vomiting, abdominal pain, and bloating in patients suffering from DG, thereby targeting the most common and bothersome symptoms of the disease. This leads to an improvement in the quality of life, making it a reliable treatment option for this disease. But while pharmacological intervention is vital, psychological support and lifestyle changes are equally important and are the reason why a multidisciplinary approach is required for the treatment of DG.
Keywords: diabetic gastroparesis; glycemic control; psychological intervention; quality of life; relamorelin; tradipitant.
Copyright © 2023, Zahid et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Horowitz M, Harding PE, Maddox AF, Wishart JM, Akkermans LM, Chatterton BE, Shearman DJ. Diabetologia. 1989;32:151–159. - PubMed
-
- Disorders of gastrointestinal motility in neurologic diseases. Camilleri M. Mayo Clin Proc. 1990;65:825–846. - PubMed
-
- Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Arch Intern Med. 2001;161:1989–1996. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials